Pancreatic cancer
A cancer of the pancreas, a gland deep in the belly that helps digest food and control blood sugar. Early on it causes few signs; later it can bring yellow skin and eyes, belly and back pain, and weight loss. Surgery gives the best chance if it can remove the whole tumour, but many people find out too late for that. It is most often found between 65 and 74, and in about half of people it has already spread by then.
Read more about pancreatic cancerTrial-stage treatments and research studies you can join
Filters
- Tests patient's own tumor-fighting immune cells for several spread cancers
Tests tumor-fighting immune cells, grown in a lab, in adults with spread cancers.
Bethesda, United StatesAge 18 to 72 - Tests olaparib after surgery for pancreatic cancer with a BRCA or PALB2 gene change
Tests olaparib after surgery in adults with pancreatic cancer and a gene change.
Aberdeen, United StatesAlso Adrian, ‘Aiea, Albuquerque, Altamonte Springs, Alton, Ames, Anaconda, Anchorage, …Age 18+ - Virtual reality headset tested for abdominal pain in digestive cancer patients
Tests virtual reality headsets for abdominal pain in adults with digestive tract cancers.
Los Angeles, United StatesAge 18 to 99 - Radiation Device Treatment for Unremovable Liver Tumors
Tests a radiation device placed inside tumors in adults with liver cancers.
Houston, United StatesAge 19+ - Tests two cancer drugs together in advanced or hard-to-treat solid tumors
Tests entinostat and ZEN003694 together in adults with advanced or resistant solid tumors.
Gainesville, United StatesAlso New Haven, Oklahoma CityAge 18+ - Testing Trastuzumab Deruxtecan and Neratinib in Solid Tumors With HER2 Gene Changes
Tests two cancer drugs together in adults with HER2 gene changes in solid tumors.
Boston, United StatesAlso Chicago, Columbus, Duarte, Gainesville, Houston, Irvine, Lancaster, Lexington, …Age 18+ - Tests BAY 3713372 in adults with MTAP-deleted solid tumors
Tests a new drug, BAY 3713372, in adults with certain solid tumors lacking MTAP.
Aurora, United StatesAlso Birmingham, Boston, Denver, Duarte, Grand Rapids, Irving, Los Angeles, Milwaukee, …Age 18+ - Testing KST-6051 in advanced cancers with a KRAS mutation
Tests the safety of KST-6051 in adults with KRAS-mutant advanced solid tumors.
Boston, United StatesAlso Fairfax, Houston, Los Angeles, Philadelphia, Salt Lake City, San Antonio, Sarasota, TampaAge 18+ - Tests ETX-929, a KRAS inhibitor, in adults with advanced KRAS-altered solid tumors
Tests ETX-929, a KRAS inhibitor, in adults with advanced solid tumors carrying KRAS changes.
Fairfax, United StatesAge 18+ - Tests chemotherapy and radiation before surgery for localized pancreatic cancer
Tests two chemotherapy drugs plus radiation before surgery in adults with pancreatic cancer.
Loma Linda, United StatesAge 18+ - Tests belzutifan in advanced tumors linked to HIF-2α gene changes
Tests belzutifan in people with advanced pheochromocytoma or pancreatic neuroendocrine tumors.
Ann Arbor, United StatesAlso Baltimore, Bethesda, Boston, Chicago, Houston, Iowa City, Los Angeles, Nashville, …Age 12+ - Tests VS-7375 in adults with advanced solid tumors carrying a KRAS G12D mutation
Tests the drug VS-7375, alone or combined, in adults with advanced KRAS G12D-mutated cancers.
Ann Arbor, United StatesAlso Baltimore, Boston, Charlottesville, Fairfax, Houston, Los Angeles, Nashville, New York, …Age 18+ - Testing Metarrestin, a New Drug, for Cancers That Have Spread
Tests metarrestin in adults and children with spreading solid tumors.
Bethesda, United StatesAlso FairwayAge 12 to 120 - Testing focused ultrasound with chemotherapy for pancreatic cancer that cannot yet be removed
Tests focused ultrasound with chemotherapy in adults with locally advanced pancreatic cancer.
Boston, United StatesAlso Charlottesville, San AntonioAge 18 to 85 - Radiotherapy with TTI-101 for Pancreatic Cancer That Is Borderline Resectable or Locally Advanced
Tests radiation with TTI-101 in adults with pancreatic cancer that is locally advanced.
Aurora, United StatesAlso St LouisAge 18+ - Lanreotide before surgery to prevent a pancreas leak in pancreatic disease
Tests lanreotide before surgery to prevent leaks in adults with pancreatic tumors.
Aitkin, United StatesAlso Albuquerque, Allentown, Ann Arbor, Ashland, Atlanta, Battle Creek, Baxter, Bethlehem, …Age 18+ - Tests ERAS-0015 alone or combined in advanced solid tumors
Tests whether ERAS-0015 is safe in adults with advanced solid tumors.
Atlanta, United StatesAlso Aurora, Boston, Fairfax, Houston, New York, Santa Rosa, Sarasota, Tampa, …Age 18 to 99 - Testing a Blood Test That Screens for Several Cancers at Once
Tests a blood test screening for multiple cancers in adults aged 45-75 without cancer.
Bethesda, United StatesAlso Chapel Hill, Charlottesville, Chesterfield, Cheyenne Wells, Cleveland, Clinton Township, Dearborn, Denver, …Age 45 to 75 - Tests atebimetinib with chemotherapy in advanced pancreatic cancer
Tests atebimetinib added to chemotherapy in adults with metastatic pancreatic cancer.
Abilene, United StatesAlso Arlington Heights, Atlanta, Austin, Belleville, Blacksburg, Chicago, Cincinnati, Columbia, …Age 18+ - Zoldonrasib added to chemotherapy for metastatic pancreatic cancer with a KRAS G12D mutation
Tests zoldonrasib plus chemotherapy against placebo plus chemotherapy in metastatic pancreatic adenocarcinoma.
Atlanta, United StatesAlso Baltimore, Boston, Chicago, Durham, East Brunswick, Gainesville, Houston, Jacksonville, …Age 18+
Where treatment stands
Approved: 16
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 43
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 1
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 2
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.
Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 226 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for pancreatic cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in United States, for you and your family.
Pancreatic cancer organisations in United States
- National Cancer Institute – Cancer Information Service (CIS)
NCI's contact center: information specialists answer cancer questions from patients, families and the public by phone, chat and email.
- American Cancer Society
Nationwide US nonprofit helping people who face cancer: research, patient services, early detection, treatment information and education, with a cancer helpline on its site.
- Cactus Cancer Society
Young adult cancer resource and community: support programs for people diagnosed with cancer as young adults.
- Cancer Hope Network
Nonprofit providing free one-on-one support to cancer patients and families by matching them with trained volunteers who have had a similar experience.
- Cancer Nation
Survivor-led US cancer advocacy organization (formerly the National Coalition for Cancer Survivorship) working on quality cancer care and survivorship resources.
- FORCE – Facing Hereditary Cancer Empowered
Nonprofit for people and families facing hereditary cancer (e.g. BRCA): information on gene mutations, risk, and support.
- Hirshberg Foundation for Pancreatic Cancer Research
Foundation (est. 1997) advancing pancreatic cancer research and providing support and information to patients and families.
- Imerman Angels
Nonprofit offering free one-on-one cancer support and personalized mentoring that connects cancer fighters, survivors and caregivers with someone who has been there.
- Let's Win Pancreatic Cancer
Online community on science-based treatments: information, doctor finder, clinical trial finder, research news, survivor stories, webinars.
- Lustgarten Foundation
Largest private funder of pancreatic cancer research; also offers patient and family resources.
- National Pancreatic Cancer Foundation (NPCF)
US nonprofit supporting pancreatic cancer patients and families with education, financial assistance, clinical trial connections and integrative therapies.
- Pancreatic Cancer Action Network (PanCAN)
Free one-to-one Patient Services: personalised information on treatment, trials and support.
- Project Purple
Nonprofit seeking a cure for pancreatic cancer and improving patients’ lives through research funding and patient assistance.
- The Seena Magowitz Foundation
Serves people affected by pancreatic cancer with virtual support groups, second opinions, educational resources, clinical trial info and bereavement support.
- Triage Cancer
National nonprofit providing free education on legal and practical issues (insurance, employment, finances) for people with cancer and caregivers.
General support in United States
- 988 Suicide & Crisis Lifeline
US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.
- MedlinePlus
Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Treatments approved outside the EU
Medicines for pancreatic cancer approved in the US or Japan that are not approved in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 9 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- CBD (cannabidiol) & Pancreatic cancer
- Vitamin C (incl. high-dose) & Pancreatic cancer
- Ivermectin & Pancreatic cancer
- Fenbendazole & Pancreatic cancer
About pancreatic cancer
Sources: NHS, NCI PDQ, MedlinePlus, Pancreatic Cancer UK, NCI SEER +1
A cancer of the pancreas, a gland deep in the belly that helps digest food and control blood sugar. Early on it causes few signs; later it can bring yellow skin and eyes, belly and back pain, and weight loss. Surgery gives the best chance if it can remove the whole tumour, but many people find out too late for that. It is most often found between 65 and 74, and in about half of people it has already spread by then.
What is it?
The pancreas is an organ in the top part of your tummy, behind the stomach. It helps digest food and makes hormones such as insulin. Pancreatic cancer usually starts in the cells that make the digestive juices.
It is not very common under 40, and the risk is higher over 65. It is most often found between 65 and 74. Smoking, long-term diabetes and long-term inflammation of the pancreas (chronic pancreatitis) raise the risk. It is also more likely if others in your family have had pancreatic cancer, or with some inherited conditions. Stopping smoking, losing weight if you need to, eating less red and processed meat and drinking less alcohol can lower your chances.
The first signs
Early pancreatic cancer causes few or no signs, and later signs are often vague. Because the pancreas lies behind other organs, a doctor cannot see or feel a tumour at a routine check-up.
- yellow skin or whites of the eyes (jaundice), often with itchy skin, darker pee and paler poo;
- a poor appetite, or losing weight without trying;
- feeling tired or low in energy;
- pain at the top of the tummy that spreads to the back, worse when eating or lying down;
- feeling or being sick, diarrhoea or constipation, or bloating and indigestion.
How doctors find out
If your family doctor thinks you could have pancreatic cancer, they send you to a specialist. You have blood tests and scans: ultrasound (sometimes from inside the body, on a thin, bendy tube called an endoscope), CT, PET or MRI. You may also have a biopsy (a small sample of cells), a small operation to look inside your tummy (laparoscopy), or ERCP, where an endoscope goes through your mouth into the gut and X-rays are taken.
Results can take several weeks. A specialist then explains what they mean; it helps to bring someone with you. The tests show how big the cancer is and whether it has spread, so your team can plan treatment with you. A specialist nurse is your main contact during and after treatment.
Current treatment
Surgery + chemo if operable, otherwise chemotherapy
Will it get worse?
It depends on where the cancer is in the pancreas, how big it is, whether it has spread, and your general health. Pancreatic cancer is often found late and spreads quickly, so it can be hard to treat. In about half of people it has already spread to distant parts of the body when it is found. Even after surgery removes the whole tumour, it often comes back.
When it cannot be cured, treatment aims to hold the cancer back, ease the symptoms and help you live longer. A palliative care team helps with cancer symptoms, pain and worry.
Medicines: what helps, and what to watch for
Chemotherapy uses medicines to kill cancer cells. It can shrink the cancer before surgery, lower the chance of it coming back after surgery, or help control symptoms when surgery is not possible. It is often a combination of different medicines. Targeted medicines and immunotherapy may work for only a small number of pancreatic cancers; tests can help predict your response to immunotherapy. In August 2026 a new targeted medicine against changes in the KRAS gene, which are found in 9 out of 10 pancreatic cancers, was approved in the United States for advanced cancer after earlier treatment.
Good to know:
- Chemotherapy for pancreatic cancer can have serious side effects. Common ones are tiredness, feeling sick, a sore mouth, diarrhoea, and numbness or tingling in the hands or feet;
- Anti-sickness medicines can help with feeling or being sick;
Eating and digestion: what helps
Many people with pancreatic cancer lose weight, and some develop diabetes. The cancer can make it hard to digest food: your pancreas can make fewer enzymes, or they cannot reach where they are needed. Enzyme capsules (pancreatic enzyme replacement therapy, PERT), taken when you eat, help you digest; when the dose is right, symptoms should get better.
- you do not need a special diet, and there are no foods to avoid;
- weight loss, indigestion, bloating, wind and changes in your poo can be signs that food is not being digested well;
- nutritional supplements can help if you have lost weight or find eating hard;
Surgery, for some people
If the cancer is found early and has not spread, surgery may remove it. The surgeon removes part of the pancreas, or in a few cases all of it, and sometimes nearby organs. For a tumour in the head of the pancreas this is called a Whipple operation. Recovery can take a long time.
If the cancer cannot be removed, an operation to bypass a blockage, or a stent placed through an endoscope to keep the bile duct or small intestine open, can help with symptoms. These operations can help with jaundice and feeling or being sick, but they do not cure the cancer. Radiotherapy is not often used, but it can be given with chemotherapy or to ease symptoms.
Is there a cure?
Rarely. Removing the whole tumour with surgery gives the best chance of living a long time, but many people find out too late for that. Because the options are limited, many experts think everyone with pancreatic cancer, even at an early stage, should think about joining a clinical trial.
Median survival
About 8 to 11 months with chemotherapy, once it has spread
Measured in: First-line treatment of metastatic pancreatic cancer, in two trials (342 and 861 patients)
The figures behind it
NCI PDQ (health professional), first-line treatment of metastatic pancreatic cancer: median overall survival 11.1 months with FOLFIRINOX vs 6.8 months with gemcitabine (trial of 342 patients); 8.5 months with gemcitabine plus nab-paclitaxel vs 6.7 months with gemcitabine (phase III trial NCT00844649, 861 patients). About half of patients have metastatic disease at diagnosis (SEER).
Sources
Written in plain words by Frontlight from these pages:
- MedlinePlus: Pancreatic Cancer
- NCI PDQ: Pancreatic Cancer Treatment (PDQ) – Patient Version
- NCI SEER: Cancer Stat Facts: Pancreatic Cancer
- NHS: Pancreatic cancer – What is pancreatic cancer?
- NHS: Pancreatic cancer – Causes
- NCI PDQ: Pancreatic Cancer Treatment (PDQ) – Health Professional Version
- NHS: Pancreatic cancer – Symptoms
- NHS: Pancreatic cancer – Tests and next steps
- NHS: Pancreatic cancer – Treatment
- NHS: Chemotherapy – Side effects
- Cancer Research UK (charity): Living with pancreatic cancer
- Pancreatic Cancer UK (charity): Diet and pancreatic cancer